title: When falsified medicines enter the supply chain: description of an incident in Kenya and lessons learned for rapid response.
abstract: Falsified and substandard medicines present serious concerns for public health. We describe an event that occurred in late 2011 involving falsified antiretroviral medicines found in the supplies of Médecins Sans Frontières (MSF) projects in Kenya. We discuss factors contributing to these falsified medicines entering the supply chain as well as the response by MSF and others. We make recommendations to help defend against future episodes of entry of falsified medicines into the supply chain as well as comments on appropriate responses in cases of falsified medicines.
authors.affiliation: University School of Medicine, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Cohn
authors.forename: Tido
authors.initials: T
authors.lastname: von Schoen-Angerer
authors.forename: Elodie
authors.initials: E
authors.lastname: Jambert
authors.forename: Guido
authors.initials: G
authors.lastname: Arreghini
authors.forename: Michelle
authors.initials: M
authors.lastname: Childs
mesh_terms: D019380:Anti-HIV Agents / Q000592:standards / Q000600:supply & distribution*; D058110:Counterfeit Drugs / Q000600:supply & distribution*; D005607:Fraud / Q000331:legislation & jurisprudence; D006801:Humans; D007630:Kenya; D061214:Patient Safety
chemical_list: D019380:Anti-HIV Agents; D058110:Counterfeit Drugs